| View |
|
DRP-12289-02
|
Sitagliptin (as phosphate)
|
Acantha
|
100 mg
|
Film-Coated Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
08 July 2027
|
| View |
|
DRP-12409-02
|
Montelukast(as sodium) + Levocetirizine hydrochloride
|
Montevo
|
10 mg/5 mg
|
Film-Coated Tablet
|
-
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
01 September 2025
|
| View |
|
DRP-12531-01
|
Losartan Potassium
|
Antoreb
|
100 mg
|
Film-coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
02 September 2027
|
| View |
|
DRP-12600-01
|
Febuxostat
|
Maxibustat 80
|
80 mg
|
Film-Coated Tablet
|
-
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
24 October 2022
|
14 September 2027
|
| View |
|
DRP-12637-01
|
Propranolol Hydrochloride
|
Indirin
|
10 mg
|
Film-coated Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
28 January 2027
|
| View |
|
DRP-12876
|
Pioglitazone (as hydrochloride)
|
Prialta
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Micro Labs Limited
|
India
|
Renewal
|
21 March 2024
|
07 May 2029
|
| View |
|
DRP-12873
|
Pioglitazone (as hydrochloride)
|
Prialta
|
15 mg
|
Tablet
|
Oral Hypoglycemic
|
Micro Labs Limited
|
India
|
Renewal
|
21 March 2024
|
07 May 2029
|
| View |
|
DRP-12875
|
Pioglitazone (as hydrochloride)
|
Prialta
|
45 mg
|
Tablet
|
-
|
Micro Labs Limited
|
India
|
PCPR Conversion
|
24 October 2022
|
08 March 2025
|
| View |
|
DRP-12878
|
Fenofibrate
|
Inofib
|
300 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
PCPR Conversion
|
24 October 2022
|
12 February 2027
|
| View |
|
DRP-12877
|
Amlodipine (as besilate)
|
Solvasc
|
5 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
19 December 2023
|
03 March 2029
|
| View |
|
DRP-12874
|
Nebivolol (as hydrochloride)
|
Nebilet
|
5mg
|
Tablet
|
Beta-blocking Agent
|
Berlin Chemie AG
|
Germany
|
Renewal
|
17 May 2024
|
10 July 2029
|
| View |
|
DRP-073-12
|
CEFACLOR (AS MONOHYDRATE)
|
KLOR-S
|
250 mg/5 mL
|
Granules for Suspension
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
Renewal
|
31 May 2024
|
09 July 2029
|
| View |
|
DRP-8238-01
|
Metformin Hydrochloride
|
Theomet-500
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose-Lowering Drugs
|
Theon Pharmaceuticals Limited
|
India
|
Renewal
|
21 March 2024
|
18 June 2029
|
| View |
|
DRP-9170-01
|
Budesonide
|
Zyics
|
250 mcg/mL (500 mcg/2 mL)
|
Suspension for Nebulization
|
Glucocorticoid
|
Legency Remedies Pvt. Ltd.
|
India
|
-
|
22 October 2022
|
22 September 2025
|
| View |
|
DRP-6795-03
|
Salbutamol (as Sulfate)
|
Asmafree
|
2 mg/ 5 mL
|
Syrup
|
Anti-asthma
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
20 October 2022
|
17 January 2027
|
| View |
|
DRP-6482-01
|
Tamsulosin Hydrochloride
|
Tamzor 200
|
200 mcg
|
Prolonged Release Tablet
|
Alpha-adrenoreceptor antagonist
|
Steril-Gene Life Sciences (P) Limited
|
India
|
CLIDP Conversion
|
20 October 2022
|
25 January 2026
|
| View |
|
DRP-7138-16
|
Ceftriaxone (as sodium)
|
Bluecozone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Zeiss pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
20 October 2022
|
27 March 2027
|
| View |
|
DRP-7279-02
|
Bortezomib
|
Borteget
|
3.5 mg
|
Lyophilized Powder for Solution for Injection (IV/SC)
|
Antineoplastic
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 October 2022
|
28 July 2027
|
| View |
|
DRP-9562-01
|
Ketoanalogues + Essential Amino Acids
|
Ketorels
|
(See reverse for unit dose formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 October 2022
|
24 February 2026
|
| View |
|
DRP-11295-03
|
Ambroxol Hydrochloride
|
None
|
30 mg
|
Tablet
|
Mucolytic
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
20 October 2022
|
24 November 2026
|